Live life with great expectations for tomorrow... and the next day... and the next.
When you're diagnosed with cancer, it's important to have every option for treatment at your disposal. Oncology Consultants makes even hard-to-come-by options available by offering clinical trials at each of our facilities, including Phase One trials typically only available in a research setting.
The drugs in these clinical trials show promise and have the potential to affect not only your recovery, but also the battle against cancer for future generations. We're exercising every possibility to help our patients overcome cancer.
A Phase Ib Multiple Ascending Dose Study of BMS-833923 (XL139) Alone or in Combination with Lenalidomide (Revlimid) plus Dexamethasone or in Combination with Bortezomib(Velcade) in Subjects with Relapsed or Refractory Multiple Myeloma (XL139)
A Phase 1b, single-arm, open-label clinical trial to evaluate corrected QT interval and drug-drug interaction of trastuzumab on carboplatin in the presence of docetaxel in patients with Her2-Positive metastatic or locally advanced inoperable cancer (H4613G)
Open-Label, Multicenter Phase 1 Study of Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor (HB-EGF) Monoclonal Antibody KHK2866 as Monotherapy in subjects with Advanced Solid Tumors and in Combination with Chemotherapy for Epithelial Ovarian, Extra-Ovarian Primary Peritoneal, or Fallopian Tube Cancer (KHK2866)
Phase I, Open-label, Multicenter, Dose-escalation, Multidose Study of MDX-1105 Administered Every 14 Days in Subjects with Selected Advanced or Recurrent solid Tumors (MDX1105-01)
A Randomized Dose Escalation, Safety and Exploratory Efficacy Study Of Kanglaite Injection Plus Gemcitabine (G+K) Versus Gemcitabine in Patients with Advanced Pancreatic Cancer (KLT-PANC-001)
An Open-Label, Randomized, Phase 2 Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Patients with Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma
A Multicenter, Open-label, Single-arm, Phase 2 Study of Abiraterone Acetate Plus Prednisone in Subjects with Advanced Prostate Cancer Without Radiographic Evidence of Metastatic Disease
A Phase I multicenter, open-label study of the effect on QTc, pharmacokinetics, safety, and preliminary efficacy of single-agent palifosfamide-tris in subjects with advanced solid tumors
A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy
©2012, Oncology Consultants
